Watson Rx Solutions Earns Two Prestigious Pharmaceutical Accreditations...

May 22, 2023

Watson Rx Solutions Earns Two Prestigious Pharmaceutical Accreditations from URAC

Distinct honor gives the Dalrada healthcare subsidiary added industry credibility and access to a larger customer base.



SAN DIEGO, CA – May 22, 2023Dalrada Financial Corporation (OTCQB: DFCO, “Dalrada”), a problem-solving innovator that takes on complex, multi-disciplinary challenges in healthcare, clean energy, precision manufacturing, and technology, announced today that its pharmaceutical subsidiary, Watson Rx Solutions (Watson Rx), has received Specialty Pharmacy Accreditation and Mail Service Pharmacy Accreditation from the Utilization Review Accreditation Commission (URAC).


WatsonRx earned both accreditations after a lengthy process that saw the pharmacy successfully complete a thorough set of training, organizational, and quality control exercises in adherence to URAC’s established 4.0 standards. Watson Rx is now permitted to display official URAC Certification Seals on its website and printed materials. Additionally, the pharmacy will be added to URAC’s list of accredited pharmacies, adding validity and providing increased visibility.


According to URAC, pharmacies that achieve the Specialty Pharmacy Accreditation demonstrate the highest value in delivering enhanced clinical services to payers, manufacturers, and providers. Additionally, they provide a quality service that demonstrates best practices, high standards, and exceptional capabilities, and a consistent and optimized experience while enhancing patient and provider satisfaction.


URAC’s Mail Service Pharmacy Accreditation standards and mail order pharmacy requirements cover core organizational quality, customer service, communications and disclosure, drug utilization management, pharmacy operations and a process for mail service outcomes measurement and quality improvement.


“Earning these two full accreditations was certainly no easy task, but it was definitely worth it,” said Adam Myers, PharmD, Pharmacist of Watson Rx Solutions. “We now join an exclusive group of pharmacies committed to ongoing quality improvement, accountability, consumer protection, and patient care, and I’m excited to move forward with the support and recommendation of URAC.”


URAC is the nation’s largest independent and nonprofit healthcare accreditation organization and a recognized leader in medical and pharmacy certification with more than 30 years of experience setting high standards of care.


To learn more about Watson Rx Solutions and its continuing mission of providing comprehensive prescription management, education, nursing, and total health management, please visit www.watsonrxsolutions.com.


About Watson Rx Solutions

Watson Rx Solutions has been in the healthcare business for more than 30 years and is deeply rooted in pharmacy as well as the health and wellbeing of the community it serves. 

Watson Rx Solutions’ goal is to redefine personalized health through unique pharmacy solutions that improve patient health outcomes. It achieves this with a dedicated team of experienced professionals providing innovative care in managing complex disease states through comprehensive prescription management, education, nursing, and total health management.

Watson Rx Solutions delivers a true end-to-end pharmacy solution. For more information, please visit www.watsonrxsolutions.com


About Dalrada Financial Corporation

Dalrada Financial Corporation (Dalrada) is a progressive organization that drives innovation to positively impact people, businesses, and the planet. The company owns and operates a global group of healthcare, clean energy, precision manufacturing, and technology companies. Each of these companies has a clearly-defined mandate to identify, address, and deliver solutions to unique economic, environmental, and efficiency problems facing public, government, and private sector organizations. Dalrada responds by developing advanced technologies, products, and services with a clear and quantifiable value, generating a significant return on investment for its clients.


Dalrada companies are on the leading edge of developing and applying innovative eco-sensitive next-generation science, engineering, and technology, serving a broad range of industries and governments. The company’s products and services significantly reduce energy costs and remove barriers for its clients, creating a more sustainable and prosperous future for us all.


Dalrada’s subsidiaries and strategic partners operate in the United States, United Kingdom, Malaysia, and India, and are centrally managed from the company’s San Diego, CA headquarters.


For more information, please visit www.dalrada.com, and follow us on LinkedIn, Facebook, and Twitter.



Statements in this press release are not historical facts. The statements are forward-looking, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management’s current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors and will be dependent upon a variety of factors including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company’s expectations regarding these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company’s success are more fully disclosed in the Company’s most recent public filings with the US Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K.


 # # #

Media Contacts:
Michael Eslinger


Stockwatchindex, LLC